The impact of pharmacogenomics on opioid induced adverse drug reactions in patients with perioperative pain
DOI:
https://doi.org/10.22024/UniKent/03/ajpp.1359Samenvatting
Background: The management of perioperative pain is critical for postoperative recovery, with opioids being a primary treatment option. However, opioid induced adverse drug reactions (ADRs) can significantly affect patient outcomes. Research indicates that genetic variation may influence the incidence and severity of opioidADRs. However, a comprehensive review into this relationship is lacking. This systematic review aims to fill this gap in the literature by exploring the impact of pharmacogenomics on opioid induced ADRs in the perioperative setting.
Methods: This review was led by the Prisma guidelines, to ensure a rigorous and consistent methodology. A thorough and comprehensive search of databases PubMed and Embase was done. Inclusion and exclusion criteria were applied to identify relevant papers. Data on opioid use, ADRs, and genetic polymorphisms were extracted and synthesized. Data was collected on two primary outcomes concerning the ADRs associatedwith opioid usage, and the frequency and severity of opioids in relation to specific genetic polymorphisms.
Results: 624 papers were initially identified, from this, 20 met the inclusion criteria for analysis and qualitative synthesis. This resulted in a wide range of key genes reported. These were implicated in drug transport (ABCB1, ABCC3), opioid receptor function (OPRK1, OPRM1, OPRD1), and metabolic pathways (CYP2D6, CYP3A4, CYP2B6, UGT2B7, COMT). Additionally, genes related to ion channel function (KCNJ6, KCNJ9)and other molecules (FAAH, OCT1, CGRP) were also assessed. Key findings suggest significant associations between selected genetic polymorphisms in the cytochrome enzyme family, OPRM1, FAAH, OCT1 andABBC3 genes, and the occurrence of opioid ADRs including respiratory depression, nausea, and vomiting.
Conclusions: This systematic review has explored the potential role of pharmacogenomics in perioperativeADRs. It can be concluded that while pharmacogenomics may look promising for enhancing personalized medicine, in the context of perioperative opioid induce ADRs, the current evidence does not yet allow for clinical application. Future larger studies are needed that could provide the statistical power to clarify the relationships observed. This could lead to a reduction of the burden of perioperative opioid induced ADRs through personalised medicine strategies.
##submission.downloads##
Gepubliceerd
Citeerhulp
Nummer
Sectie
Licentie
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
AJPP requests that, as the creator(s)/author(s) of the manuscript you are submitting, that you assign certain rights to the manuscript to the AJPP in exchange for undertaking to publish the article in electronic form and, in general, to pursue its dissemination throughout the world. The rights the AJPP requests are:
- The right to publish the article in electronic form or in any other form it may choose that is in keeping with its role as a scholarly journal with the goal of disseminating the work as widely as possible;
- The right to be the sole publisher of the article for a period of 12 months;
- The right to make the article available to the public within a period of not more than 24 months, as determined by relevant journal staff of the AJPP;
- The right to grant republication rights to itself or others in print, electronic, or any other form, with any revenues accrued to be shared equally between the author(s) and the journal;
- The right to administer permission to use portions of the article as requested by others, seeking recompense when the AJPP sees it as warranted;
- The right to seek or take advantage of opportunities to have the article included in a database aimed at increasing awareness of it;
- As the author(s), the AJPP wishes you to retain the right to republish the article, with acknowledgement of the AJPP as the original publisher, in whole or in part, in any other pbulication of your own, including any anthology that you might edit with up to three others;
- As the author(s), the AJPP wishes you to retain the right to place the article on your personal Web page or respository of your university or institution. The AJPP askes that you include this notice: A fully edited, peer-reviewed version of this article was first published by the Advanced Journal of Professional Practice, <Year>, <Volume>, <Issue>, <Page Numbers>.
- You retain the right to unrestricted use of your paper for yourself or for your own teaching purposes.
BY AGREEING TO THE FOREGOING, YOU CONFIRM THAT THE MANUSCRIPT YOU ARE SUBMITTING HAS NOT BEEN PUBLISHED ELSEWHERE IN WHOLE OR IN PART, AND THAT NO AGREEMENT TO PUBLISH IS OUTSTANDING.
SHOULD THE ARTICLE CONTAIN MATERIAL WHICH REQUIRES WRITTEN PERMISSION FOR INCLUSION, YOU AGREE THAT IT IS YOUR OBLIGATION IN LAW TO IDENTIFY SUCH MATERIAL TO THE EDITOR OF THE AJPP AND TO OBTAIN SUCH PERMISSION. THE AJPP WILL NOT PAY ANY PERMISSION FEES. SHOULD THE AJPP BE OF THE OPINION THAT SUCH PERMISSION IS NECESSARY, IT WILL REQUIRE YOU TO PURSUE SUCH PERMISSSION PRIOR TO PUBLICATION.
AS AUTHOR(S), YOU WARRANT THAT THE ARTICLE BEING SUBMITTED IS ORIGINAL TO YOU.
Provided the foregoing terms are satisfactory, and that you are in agreement with them, please indicate your acceptance by checking the appropriate box and proceed with your submission.
